Inaktiver Wert

Transkripte EnteroMedics Inc Nasdaq

Aktien

US29365M2089

Transkripte

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024	01.04.
Transcript : ReShape Lifesciences Inc., Q3 2023 Earnings Call, Nov 08, 2023	08.11.
Transcript : ReShape Lifesciences Inc., Q2 2023 Earnings Call, Aug 07, 2023	07.08.23
Transcript : ReShape Lifesciences Inc., Q1 2023 Earnings Call, May 15, 2023	15.05.23
Transcript : ReShape Lifesciences Inc., 2022 Earnings Call, Apr 25, 2023	25.04.23
ReShape Lifesciences Inc. gibt eine Umsatzprognose ab	14.11.22	CI
Transcript : ReShape Lifesciences Inc., Q3 2022 Earnings Call, Nov 14, 2022	14.11.22
Transcript : ReShape Lifesciences Inc., Q2 2022 Earnings Call, Aug 15, 2022	15.08.22
Transcript : ReShape Lifesciences Inc., Q1 2022 Earnings Call, May 23, 2022	23.05.22
Transcript : ReShape Lifesciences Inc., Q4 2021 Earnings Call, Mar 28, 2022	28.03.22
Transcript : ReShape Lifesciences Inc., Q3 2021 Earnings Call, Nov 11, 2021	11.11.21
Transcript : ReShape Lifesciences Inc., Q2 2021 Earnings Call, Aug 16, 2021	16.08.21
Transcript : Obalon Therapeutics, Inc. - Shareholder/Analyst Call	25.05.21
Transcript : ReShape Lifesciences Inc., Q1 2021 Earnings Call, May 18, 2021	18.05.21
Transcript : ReShape Lifesciences Inc., Q4 2020 Earnings Call, Mar 10, 2021	10.03.21
Transcript : ReShape Lifesciences Inc., Q3 2020 Earnings Call, Nov 12, 2020	12.11.20
Transcript : ReShape Lifesciences Inc., Q2 2020 Earnings Call, Aug 13, 2020	13.08.20
Transcript : ReShape Lifesciences Inc., Q4 2019 Earnings Call, Mar 26, 2020	26.03.20
Transcript : Obalon Therapeutics, Inc., Q4 2019 Earnings Call, Feb 27, 2020	27.02.20
Transcript : ReShape Lifesciences Inc., Q3 2019 Earnings Call, Nov 14, 2019	14.11.19

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Transkripte EnteroMedics Inc Nasdaq

Aktien

US29365M2089

Transkripte

Filter